3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
NET
1
Genitourinary
1
Endocrine
1
CNS
1
Breast
1
Conditions
Prostatic Neoplasms
1
Neuroendocrine Tumors
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Octreotide
4
Everolimus
4
lanreotide
3
pasireotide
2
Carboplatin
2
surufatinib
1
lutetium Lu 177 dotatate
1
gadoteridol
1
gadoterate meglumine
1
gadolinium ethoxybenzyl DTPA
1
gadodiamide
1
gadobutrol
1
gadobenic acid
1
arginyllysine
1
Surveys and Questionnaires
1
Sunitinib
1
Somatostatin
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Neuropsychological Tests
1
Magnetic Resonance Spectroscopy
1
Diazoxide
1
Cisplatin
1
Cabergoline
1
64Cu-DOTATATE
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
gadoterate meglumine
×
NET
×
Clear all
NCT04373564
2026-01-22
ODYSSEY
Guerbet
Phase 4
Recruiting
2,076 enrolled